- Pfizer Inches Down On Mixed Report As Cost Cuts Boost Earnings Investor’s Business Daily
- Pfizer Earnings Beat Isn’t Enough to Ease Stock Worries Barron’s
- Pfizer leans on cost cuts to offset falling revenue Reuters
- Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall CNBC
- Pfizer Announces Another $1.7B in Cost Savings, Including R&D Revamp BioSpace